Expression of the c-myc protein is down-regulated at the terminal stages during in vitro differentiation of B-type chronic lymphocytic leukemia cells.
摘要:
The translocated oncogene in (BL) and () has been proposed to be expressed at a stage of differentiation at which the gene is normally silent, resulting in a continuous proliferation and an inhibited terminal differentiation. To determine whether is differently expressed at the various stages of the differentiation pathway, we used B-type (B-CLL) , representing resting B lymphocytes, inducible to proliferation and/or differentiation in vitro. The , and Ig lambda-light chain and PCA-1 antigen as markers of B-, were analyzed in single, morphologically defined by immunocytochemical double-staining. The proliferation of individual was determined by 3H-incorporation and by analysis of Ki-67 antigen expression. The results show that the level of expression correlates to the stage of differentiation and to the proliferative activity. Uninduced resting did not express . The was observed in the highest amount at the proliferative B-lymphoblast stage of maturation and was reduced in plasmablasts and undetectable in plasma . The results suggest that maturation of B into nonproliferative, terminally differentiated plasma is associated with a downregulated expression and thus support the view that the deregulated gene in BL and is expressed at an inappropriate stage of maturation and thereby inhibits terminal differentiation.
展开
DOI:
doi:10.1002/ajh.2830360317
被引量:
年份:
1991
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!